Extended Release Tablet Of Antidiabetic Drug: Development, Optimization And Evaluation

Patel, Dhara; Patel, Dhara

ISBN 10: 3659448141 ISBN 13: 9783659448140
Editore: Lap Lambert Academic Publishing, 2013
Nuovi Paperback

Da Revaluation Books, Exeter, Regno Unito Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Venditore AbeBooks dal 6 gennaio 2003

Questo articolo specifico non è più disponibile.

Riguardo questo articolo

Descrizione:

132 pages. 8.66x5.91x0.30 inches. In Stock. Codice articolo __3659448141

Segnala questo articolo

Riassunto:

According to WHO 2012 report 347 million people worldwide have Diabetes. Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. Glipizide has a relatively short elimination half-life (2–4 h) and practically water-insoluble BCS class-II drug thereby requiring two to three times daily dosing in large number of patients, which often leads to non-compliance. The present work was aimed towards the development of extended release formulations of glipizide in order to achieve plasma concentration profile up to 24 hrs using based on matrix technology resulting in a better patient compliance. Limited work has been performed and published on hydroxy ethyl cellulose and hydroxyl propyl cellulose as an oral extended release hydrophilic matrix system. This book is helpful to the researcher who works with development of extended release matrix tablet formulations using hydroxy ethyl cellulose and hydroxy propyl cellulose.

L'autore: Dhara B. Patel, M.Pharm, PhD., Studied Pharmaceutics and Pharmaceutical technology at Hemchandracharya North Gujarat University. Assistant Professor at Department of Pharmaceutical Sciences, HNGU, Patan-384265, Gujarat, India.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: Extended Release Tablet Of Antidiabetic Drug...
Casa editrice: Lap Lambert Academic Publishing
Data di pubblicazione: 2013
Legatura: Paperback
Condizione: Brand New

I migliori risultati di ricerca su AbeBooks

Immagini fornite dal venditore

Dhara Patel
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo Brossura
Print on Demand

Da: moluna, Greven, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Patel DharaDhara B. Patel, M.Pharm, PhD., Studied Pharmaceutics and Pharmaceutical technology at Hemchandracharya North Gujarat University. Assistant Professor at Department of Pharmaceutical Sciences, HNGU, Patan-384265, Gujarat, In. Codice articolo 159141167

Contatta il venditore

Compra nuovo

EUR 50,66
Spedizione EUR 48,99
Spedito da Germania a U.S.A.

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Dhara Patel
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo Taschenbuch

Da: preigu, Osnabrück, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. Extended Release Tablet Of Antidiabetic Drug | Development, optimization and evaluation | Dhara Patel | Taschenbuch | 132 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9783659448140 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Codice articolo 113178861

Contatta il venditore

Compra nuovo

EUR 53,25
Spedizione EUR 70,00
Spedito da Germania a U.S.A.

Quantità: 5 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Dhara Patel
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo Taschenbuch
Print on Demand

Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -According to WHO 2012 report 347 million people worldwide have Diabetes. Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. Glipizide has a relatively short elimination half-life (2-4 h) and practically water-insoluble BCS class-II drug thereby requiring two to three times daily dosing in large number of patients, which often leads to non-compliance. The present work was aimed towards the development of extended release formulations of glipizide in order to achieve plasma concentration profile up to 24 hrs using based on matrix technology resulting in a better patient compliance. Limited work has been performed and published on hydroxy ethyl cellulose and hydroxyl propyl cellulose as an oral extended release hydrophilic matrix system. This book is helpful to the researcher who works with development of extended release matrix tablet formulations using hydroxy ethyl cellulose and hydroxy propyl cellulose. 132 pp. Englisch. Codice articolo 9783659448140

Contatta il venditore

Compra nuovo

EUR 61,90
Spedizione EUR 23,00
Spedito da Germania a U.S.A.

Quantità: 2 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Dhara Patel
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo Taschenbuch
Print on Demand

Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -According to WHO 2012 report 347 million people worldwide have Diabetes. Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. Glipizide has a relatively short elimination half-life (2-4 h) and practically water-insoluble BCS class-II drug thereby requiring two to three times daily dosing in large number of patients, which often leads to non-compliance. The present work was aimed towards the development of extended release formulations of glipizide in order to achieve plasma concentration profile up to 24 hrs using based on matrix technology resulting in a better patient compliance. Limited work has been performed and published on hydroxy ethyl cellulose and hydroxyl propyl cellulose as an oral extended release hydrophilic matrix system. This book is helpful to the researcher who works with development of extended release matrix tablet formulations using hydroxy ethyl cellulose and hydroxy propyl cellulose.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 132 pp. Englisch. Codice articolo 9783659448140

Contatta il venditore

Compra nuovo

EUR 61,90
Spedizione EUR 60,00
Spedito da Germania a U.S.A.

Quantità: 1 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Dhara Patel
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo Taschenbuch
Print on Demand

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - According to WHO 2012 report 347 million people worldwide have Diabetes. Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. Glipizide has a relatively short elimination half-life (2-4 h) and practically water-insoluble BCS class-II drug thereby requiring two to three times daily dosing in large number of patients, which often leads to non-compliance. The present work was aimed towards the development of extended release formulations of glipizide in order to achieve plasma concentration profile up to 24 hrs using based on matrix technology resulting in a better patient compliance. Limited work has been performed and published on hydroxy ethyl cellulose and hydroxyl propyl cellulose as an oral extended release hydrophilic matrix system. This book is helpful to the researcher who works with development of extended release matrix tablet formulations using hydroxy ethyl cellulose and hydroxy propyl cellulose. Codice articolo 9783659448140

Contatta il venditore

Compra nuovo

EUR 61,90
Spedizione EUR 61,08
Spedito da Germania a U.S.A.

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Patel, Dhara; Patel, Dhara
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo Paperback

Da: Revaluation Books, Exeter, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Paperback. Condizione: Brand New. 132 pages. 8.66x5.91x0.30 inches. In Stock. Codice articolo 3659448141

Contatta il venditore

Compra nuovo

EUR 114,72
Spedizione EUR 11,59
Spedito da Regno Unito a U.S.A.

Quantità: 1 disponibili

Aggiungi al carrello

Foto dell'editore

Patel, Dhara
ISBN 10: 3659448141 ISBN 13: 9783659448140
Nuovo paperback

Da: Mispah books, Redhill, SURRE, Regno Unito

Valutazione del venditore 4 su 5 stelle 4 stelle, Maggiori informazioni sulle valutazioni dei venditori

paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Codice articolo ERICA82936594481416

Contatta il venditore

Compra nuovo

EUR 192,23
Spedizione EUR 28,98
Spedito da Regno Unito a U.S.A.

Quantità: 1 disponibili

Aggiungi al carrello